Charles Schwab Investment Management Inc Rubius Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.79 - $5.98 $58,662 - $444,050	-74,256 Reduced 25.44%	217,621 $186,000
Q1 2022 May 13, 2022	SELL	$4.25 - $10.4 $56,903 - $139,245	-13,389 Reduced 4.39%	291,877 $1.61 Million
Q4 2021 Feb 11, 2022	BUY	$9.68 - $17.74 $59,473 - $108,994	6,144 Added 2.05%	305,266 $2.96 Million
Q3 2021 Nov 16, 2021	SELL	$17.6 - $25.91 $121,880 - $179,426	-6,925 Reduced 2.26%	299,122 $5.35 Million
Q2 2021 Aug 16, 2021	BUY	$22.26 - $28.43 $740,278 - $945,468	33,256 Added 12.19%	306,047 $7.47 Million
Q1 2021 May 17, 2021	BUY	$8.02 - $32.01 $239,525 - $956,010	29,866 Added 12.29%	272,791 $7.23 Million
Q4 2020 Feb 16, 2021	BUY	$4.23 - $8.73 $30,891 - $63,755	7,303 Added 3.1%	242,925 $1.84 Million
Q3 2020 Nov 13, 2020	BUY	$4.65 - $6.25 $23,096 - $31,043	4,967 Added 2.15%	235,622 $1.18 Million
Q2 2020 Aug 14, 2020	BUY	$4.01 - $6.88 $69,048 - $118,466	17,219 Added 8.07%	230,655 $1.38 Million
Q1 2020 May 15, 2020	BUY	$3.74 - $9.84 $11,006 - $28,959	2,943 Added 1.4%	213,436 $950,000
Q4 2019 Feb 07, 2020	BUY	$7.23 - $14.12 $25,297 - $49,405	3,499 Added 1.69%	210,493 $2 Million
Q3 2019 Nov 08, 2019	BUY	$7.85 - $15.75 $712,568 - $1.43 Million	90,773 Added 78.1%	206,994 $1.63 Million
Q2 2019 Aug 09, 2019	BUY	$13.5 - $19.94 $155,331 - $229,429	11,506 Added 10.99%	116,221 $1.83 Million
Q1 2019 May 14, 2019	BUY	$13.27 - $18.51 $567,982 - $792,265	42,802 Added 69.13%	104,715 $1.9 Million
Q4 2018 Feb 14, 2019	SELL	$13.83 - $22.97 $10,234 - $16,997	-740 Reduced 1.18%	61,913 $996,000
Q3 2018 Nov 13, 2018	BUY	$20.06 - $26.94 $1.26 Million - $1.69 Million	62,653 New	62,653 $1.5 Million

Others Institutions Holding RUBY

# of Institutions

Shares Held

325

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

325
Shares

$0
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Rubius Therapeutics, Inc.

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

More about RUBY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account